Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stibium metallicum praeparatum is a homeopathic and anthroposophic medicinal preparation derived from antimony (stibium). It is used in various potencies (e.g., D6, D10, D30) and pharmaceutical forms such as triturations and ampoules for oral or injectable use. The drug is primarily indicated in complementary medicine for the prevention of chemotherapy-induced peripheral neuropathy (CIPN), especially paclitaxel-induced neuropathy[1][4]. Other reported uses include adjunctive treatment of bronchial asthma, cardiac arrhythmia[5], venous congestion, bleeding disorders such as haemorrhoids and varicose veins[6][8][10], neuralgic pain, inflammatory conditions of the gastrointestinal tract and skin, menstrual disorders in women, prostate inflammation in men[6][8][10], and support during psychological distress or palliative care situations[9]. Its mechanism of action is not established by conventional pharmacology; its effects are attributed to homeopathic/anthroposophic principles rather than direct molecular targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on stibium metallicum praeparatum.